Histone deacetylase inhibitors with arylpyrazolyl motifs

Details for Australian Patent Application No. 2006312083 (hide)

Owner Merck & Co., Inc.

Inventors Witter, David J.; Close, Joshua; Heidebrecht, Richard W.; Miller, Thomas A.; Tempest, Paul; Stanton, Matthew G.; Kattar, Solomon; Sloman, David

Agent Spruson & Ferguson

Pub. Number AU-A-2006312083

PCT Pub. Number WO2007/055941

Priority 60/733,340 03.11.05 US

Filing date 30 October 2006

Wipo publication date 18 May 2007

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/055941 Priority application(s): WO2007/055941

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006312084-Substituted nicotinamide compounds

2006312076-Flame spraying process and apparatus